Moderna on Monday said laboratory tests have shown its COVID-19 vaccine could protect against the U.K. strain but that it is less effective -- while still meeting efficacy benchmarks -- against the strain identified in South Africa....
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!